RONALD CALHOUN: Open Payments
NPI 1942210745 · STEVENSON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 21 payments from 13 companies in 2025. Trend: 2023 $580 · 2024 $600 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Inspire Medical Systems, Inc. | 1 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Indivior Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $24 |
| Braeburn Inc. | 1 | $22 |
| Amgen Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: CAPLYTA, XIFAXAN, INSPIRE, VOQUEZNA, REXULTI, SUBLOCADE, Korlym, BRIXADI.
Industry payments across AL — which companies pay providers there.
